Professor Tamara Galloway's research has identified for the first time
associations between exposure to one of the world's most widely used
chemicals, bisphenol A (BPA), and an elevated risk of developing
cardiovascular disease (CVD), the leading cause of death globally.
Specifically the 25% of individuals with highest urinary BPA levels,
compared to the 25% with the lowest levels, have a 1.5-2 fold increased
risk of developing CVD. This finding has influenced international policy
debate and resulted in restrictions on the use of BPA in food contact
materials, and is stimulating industry investment into safer chemical
alternatives. Furthermore it has raised public awareness of the associated
Research by Professors David Melzer and Tamara Galloway on the
bioactivity of Bisphenol A (BPA) an oestrogenic chemical widely used in
plastics, has influenced public policy on an international scale and led
to improvements in human health. They demonstrated that BPA is active in
the human body at commonly experienced concentrations and that higher
exposures are associated with hormonal imbalance and coronary artery
disease. The outcomes have stimulated policy debate and led to a
reappraisal of the environmental risks associated with BPA exposure.
Regulatory authorities across the world are now committed to reducing BPA
residues in food and beverages.